Thromboxane

WikiDoc Resources for Thromboxane
Articles
Most recent articles on Thromboxane Most cited articles on Thromboxane Review articles on Thromboxane Articles on Thromboxane in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Thromboxane Images of Thromboxane Photos of Thromboxane Podcasts & MP3s on Thromboxane Videos on Thromboxane
Evidence Based Medicine
Cochrane Collaboration on Thromboxane Bandolier on Thromboxane TRIP on Thromboxane
Clinical Trials
Ongoing Trials on Thromboxane at Clinical Trials.gov Trial results on Thromboxane Clinical Trials on Thromboxane at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Thromboxane NICE Guidance on Thromboxane NHS PRODIGY Guidance FDA on Thromboxane CDC on Thromboxane
Books
Books on Thromboxane
News
Thromboxane in the news Be alerted to news on Thromboxane News trends on Thromboxane
Commentary
Blogs on Thromboxane
Definitions
Definitions of Thromboxane
Patient Resources / Community
Patient resources on Thromboxane Discussion groups on Thromboxane Patient Handouts on Thromboxane Directions to Hospitals Treating Thromboxane Risk calculators and risk factors for Thromboxane
Healthcare Provider Resources
Symptoms of Thromboxane Causes & Risk Factors for Thromboxane Diagnostic studies for Thromboxane Treatment of Thromboxane
Continuing Medical Education (CME)
CME Programs on Thromboxane
International
Thromboxane en Espanol Thromboxane en Francais
Business
Thromboxane in the Marketplace Patents on Thromboxane
Experimental / Informatics
List of terms related to Thromboxane

Overview

Thromboxane A2

Error creating thumbnail: File missing

Thromboxane B2

Thromboxane is a member of the family of lipids known as eicosanoids. The two major thromboxanes are thromboxane A2 and thromboxane B2.

Thromboxane is named for its role in clot formation (thrombosis).

Production

Enzymes and substrates associated with thromoboxane and prostacyclin synthesis.

It is produced in platelets by thromboxane-A synthase from the endoperoxides produced by the cyclooxygenase (COX) enzyme from arachidonic acid.

Mechanism

Thromboxane acts by binding to any of the thromboxane receptors, G-protein coupled receptors coupled to the G protein G_q.

Functions

Thromboxane is a vasoconstrictor and a potent hypertensive agent, and it facilitates platelet aggregation.

It is in homeostatic balance in the circulatory system with prostacyclin, a related compound. The mechanism of secretion of thromboxanes from platelets is still unclear.

Role of A2 in platelet aggregation

Thromboxane A₂ (TXA₂), produced by activated platelets, has prothrombotic properties, stimulating activation of new platelets as well as increasing platelet aggregation.

Platelet aggregation is achieved by mediating expression of the glycoprotein complex GP IIb/IIIa in the cell membrane of platelets. Circulating fibrinogen binds these receptors on adjacent platelets, further strengthening the clot.

Pathology

It is believed that the vasoconstriction caused by thromboxanes plays a role in Prinzmetal's angina.

Suppression

The widely used drug aspirin acts by inhibiting the ability of the COX enzyme to synthesize the precursors of thromboxane within platelets.

It inhibits the COX enzyme both non-competitively and irreversibly.

The side effect of this is that people who regularly take aspirin will suffer from excessive bleeding whenever the skin is perforated.

External links

• Thromboxanes at the US National Library of Medicine Medical Subject Headings (MeSH)